Helen Elizabeth Hanby

Director/Board Member at NIGHTSTAR THERAPEUTICS PLC

58 year

Health Services

Health Technology

Finance

Profile

Helen Elizabeth Hanby currently works at NightstaRx Ltd., as Secretary & Director from 2019, Nightstar Therapeutics Ltd., as Secretary & Director from 2019, and Tungsten Bidco Ltd., as Secretary & Director from 2019.

Helen Elizabeth Hanby active positions

Companies	Position	Start
NIGHTSTAR THERAPEUTICS PLC	Director/Board Member	2019-06-06
Tungsten Bidco Ltd. Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the private company is based in Maidenhead, UK.	Director/Board Member	2019-06-03
NightstaRx Ltd. NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom.	Director/Board Member	2019-06-06

All active positions of Helen Elizabeth Hanby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Elizabeth Hanby's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
NightstaRx Ltd. NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom.	Health Services
Nightstar Therapeutics Ltd. Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom.	Health Technology
Tungsten Bidco Ltd. Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the private company is based in Maidenhead, UK.	Finance

See company connections